REPORTS

Global Biomarker Market Size study, by Disease Indication (Cancer, Cardiovascular Disorder, Infectious Diseases, Neurological Disorder, Immunological Disorder, Others), by Application (Diagnosis, Drug Discovery and Development, Others), by End-Use (Hospitals, Research Laboratories, Ambulatory Surgical Centers, Diagnostic Laboratories), by Product Type (Biomarker Test Kits, Biomarker Analyzers) and Regional Forecasts 2018-2025

Publishing Date : 13 Feb 2019 Report Code : Bizwit_1744 Pages : 200 Category : Healthcare and Pharma
Description

Global Biomarker Market to reach USD XX billion by 2025. Global Biomarker Market valued approximately USD 29.5 billion in 2017 is anticipated to grow with a healthy growth rate of more than 13% over the forecast period 2018-2025. The Biomarker Market is continuously growing in across the world over the upcoming years. Biomarker is a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures and biological procedures. It is also known as signature molecule or molecular marker. Increasing diagnostic applications of biomarkers, increasing R&D funding for pharma and biotech companies, increasing number of CROs and low cost of clinical trials in developing countries are the substantial driving factors of the market across the world. Furthermore, growing demand from emerging economies is creating numerous opportunity in the market over the upcoming years. Biomarkers are used to assist medical professionals to take effective clinical decisions and it also helps in diagnosing the health of patients. Also, biomarkers are predicting drug efficacy quickly than conventional clinical endpoints. These benefits of Biomarker also increasing demand among its end-user industries over the upcoming years. However, high capital investments and low cost-benefit ratio, poorly suited regulatory and reimbursement systems, and technical issues related to sample collection and storage is the restraining factors of the market across the globe. The regional analysis of Global Biomarker Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region in the global Biomarker market due to growing prevalence of cancer and increasing adoption of precision medicine in the region. Europe is also estimated to grow in the global Biomarker market over the forecasted period 2018-2025. However, Asia-Pacific is also witnessed to grow at higher rate over the forecasted period 2018-2025. The major market player included in this report are: Abbott Laboratories Medtronic BG Medicine Inc. Hoffmann LA Roche Ltd. Siemens Healthnineers Nexus-DX Qiagen N.V. Lifesign LLC The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below: By Disease Indication: ? Cancer, Cardiovascular Disorder ? Infectious Diseases ? Neurological Disorder ? Immunological Disorder ? Others By Application: ? Diagnosis ? Drug Discovery and Development ? Others By End-Use: ? Hospitals ? Research Laboratories ? Ambulatory Surgical Centers ? Diagnostic Laboratories By Product Type: ? Biomarker Test Kits ? Biomarker Analyzers By Regions: ? North America o U.S. o Canada ? Europe o UK o Germany ? Asia Pacific o China o India o Japan ? Latin America o Brazil o Mexico ? Rest of the World Furthermore, years considered for the study are as follows: Historical year - 2015, 2016 Base year - 2017 Forecast period - 2018 to 2025 Target Audience of the Global Biomarker Market in Market Study: ? Key Consulting Companies & Advisors ? Large, medium-sized, and small enterprises ? Venture capitalists ? Value-Added Resellers (VARs) ? Third-party knowledge providers ? Investment bankers ? Investors

Table of Figures

TABLE OF CONTENTS Chapter 1. Executive Summary 1.1. Market Snapshot 1.2. Key Trends 1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion) 1.3.1. Biomarker Market, by Disease Indication, 2015-2025 (USD Billion) 1.3.2. Biomarker Market, by Application, 2015-2025 (USD Billion) 1.3.3. Biomarker Market, by End-Use, 2015-2025 (USD Billion) 1.3.4. Biomarker Market, by Product Type, 2015-2025 (USD Billion) 1.3.5. Biomarker Market, by Region, 2015-2025 (USD Billion) 1.4. Estimation Methodology 1.5. Research Assumption Chapter 2. Biomarker Market Definition and Scope 2.1. Objective of the Study 2.2. Market Definition & Scope 2.2.1. Industry Evolution 2.2.2. Scope of the Study 2.3. Years Considered for the Study 2.4. Currency Conversion Rates Chapter 3. Biomarker Market Dynamics 3.1. See Saw Analysis 3.1.1. Market Drivers 3.1.2. Market Challenges 3.1.3. Market Opportunities Chapter 4. Biomarker Market Industry Analysis 4.1. Porter's 5 Force Model 4.1.1. Bargaining Power of Buyers 4.1.2. Bargaining Power of Suppliers 4.1.3. Threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.1.6. Futuristic Approach to Porter's 5 Force Model 4.2. PEST Analysis 4.2.1. Political Scenario 4.2.2. Economic Scenario 4.2.3. Social Scenario 4.2.4. Technological Scenario 4.3. Value Chain Analysis 4.3.1. Supplier 4.3.2. Manufacturers/Service Provider 4.3.3. Distributors 4.3.4. End-Uses 4.4. Key Buying Criteria 4.5. Regulatory Framework 4.6. Cost Structure Analysis 4.6.1. Raw Material Cost Analysis 4.6.2. Manufacturing Cost Analysis 4.6.3. Labour Cost Analysis 4.7. Investment Vs Adoption Scenario 4.8. Analyst Recommendation & Conclusion Chapter 5. Biomarker Market, by Disease Indication 5.1. Market Snapshot 5.2. Market Performance - Potential Model 5.3. Key Market Players 5.4. Biomarker Market, Sub Segment Analysis 5.4.1. Cancer 5.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion) 5.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) 5.4.2. Cardiovascular Disorder 5.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion) 5.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) 5.4.3. Infectious Disease 5.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion) 5.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) 5.4.4. Neurological Disorder 5.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion) 5.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) 5.4.5. Immunological Disorder 5.4.5.1. Market estimates & forecasts, 2015-2025 (USD Billion) 5.4.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) 5.4.6. Others 5.4.6.1. Market estimates & forecasts, 2015-2025 (USD Billion) 5.4.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) Chapter 6. Biomarker Market, by Application 6.1. Market Snapshot 6.2. Market Performance - Potential Model 6.3. Key Market Players 6.4. Biomarker Market, Sub Segment Analysis 6.4.1. Diagnosis 6.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion) 6.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) 6.4.2. Drug Discovery and Development 6.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion) 6.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) 6.4.3. Others 6.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion) 6.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) Chapter 7. Biomarker Market, by End-Use 7.1. Market Snapshot 7.2. Market Performance - Potential Model 7.3. Key Market Players 7.4. Biomarker Market, Sub Segment Analysis 7.4.1. Hospitals 7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion) 7.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.4.2. Research Laboratories 7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion) 7.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.4.3. Ambulatory Surgical Centers 7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion) 7.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.4.4. Diagnostic Laboratories 7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion) 7.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) Chapter 8. Biomarker Market, by Product Type 8.1. Market Snapshot 8.2. Market Performance - Potential Model 8.3. Key Market Players 8.4. Biomarker Market, Sub Segment Analysis 8.4.1. Biomarker Test Kits 8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion) 8.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) 8.4.2. Biomarker Analyzers 8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion) 8.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) Chapter 9. Biomarker Market, by Regional Analysis 9.1. Biomarker Market, Regional Market Snapshot (2015-2025) 9.2. North America Biomarker Market Snapshot 9.2.1. U.S. 9.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion) 9.2.1.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.2.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.2.1.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.2.1.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.2.2. Canada 9.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion) 9.2.2.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.2.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.2.2.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.2.2.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.3. Europe Biomarker Market Snapshot 9.3.1. U.K. 9.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion) 9.3.1.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.3.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.3.1.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.3.1.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.3.1.6. 9.3.2. Germany 9.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion) 9.3.2.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.3.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.3.2.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.3.2.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.3.3. France 9.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion) 9.3.3.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.3.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.3.3.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.3.3.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.3.4. Rest of Europe 9.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion) 9.3.4.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.3.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.3.4.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.3.4.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.4. Asia Biomarker Market Snapshot 9.4.1. China 9.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion) 9.4.1.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.4.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.4.1.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.4.1.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.4.2. India 9.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion) 9.4.2.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.4.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.4.2.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.4.2.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.4.3. Japan 9.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion) 9.4.3.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.4.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.4.3.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.4.3.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.4.4. Rest of Asia Pacific 9.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion) 9.4.4.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.4.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.4.4.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.4.4.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.5. Latin America Biomarker Market Snapshot 9.5.1. Brazil 9.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion) 9.5.1.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.5.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.5.1.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.5.1.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.5.2. Mexico 9.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion) 9.5.2.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.5.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.5.2.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.5.2.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.6. Rest of The World 9.6.1. South America 9.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion) 9.6.1.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.6.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.6.1.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.6.1.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.6.2. Middle East and Africa 9.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion) 9.6.2.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.6.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.6.2.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion) 9.6.2.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion) Chapter 10. Competitive Intelligence 10.1. Company Market Share (Subject to Data Availability) 10.2. Top Market Strategies 10.3. Company Profiles 10.3.1. Abbott Laboratories 10.3.1.1. Overview 10.3.1.2. Financial (Subject to Data Availability) 10.3.1.3. Summary 10.3.1.4. Recent Developments 10.3.2. Medtronic 10.3.3. BG Medicine Inc. 10.3.4. Hoffmann LA Roche Ltd. 10.3.5. Siemens Healthnineers 10.3.6. Nexus-DX 10.3.7. Qiagen N.V. 10.3.8. Lifesign LLC Chapter 11. Research Process 11.1. Research Process 11.1.1. Data Mining 11.1.2. Analysis 11.1.3. Market Estimation 11.1.4. Validation 11.1.5. Publishing 11.1.6. Research Assumption